文献速递自身免疫性与大疱性皮肤病

天疱疮与神经系统疾病的关联

Association Between Pemphigus and Neurologic Diseases.
PubMed 文献 · JAMA Dermatol · 2018-01-01

基于以色列Clalit健康服务数据库的回顾性人口横断面研究,纳入2004年1月1日至2014年12月31日1985例新诊断天疱疮患者与9874名年龄、性别、族裔匹配的对照,比较痴呆、癫痫、帕金森病和多发性硬化的比例。结果显示天疱疮与痴呆、帕金森病和癫痫存在关联,医生应意识到这种可能的关联并仔细评估患者是否合并神经系统疾病。

要点

  • 天疱疮患者中痴呆比例为31.3% vs 对照18.8%,OR 1.97(95%CI 1.77-2.20)。
  • 帕金森病比例为8.8% vs 4.4%,OR 2.09(95%CI 1.74-2.51)。
  • 癫痫比例为3.7% vs 2.1%,OR 1.78(95%CI 1.36-2.33);多发性硬化OR 1.65(95%CI 0.34-8.22)。

核心结论

  • 观察到天疱疮与特定神经系统疾病(包括痴呆、帕金森病和癫痫)之间存在关联。
  • 治疗天疱疮患者的医生应意识到这种可能的关联。
  • 天疱疮患者应仔细评估是否合并神经系统疾病并接受适当治疗。

研究设计与样本

  • 回顾性人口横断面研究,研究时间为2004年1月1日至2014年12月31日。
  • 使用以色列最大公共卫生组织Clalit健康服务数据库,涵盖社区诊所、初级保健和转诊中心、门诊和住院医疗。
  • 纳入1985例新诊断天疱疮患者和9874名对照,对照按年龄、性别和族裔匹配。
  • 采用逻辑回归计算痴呆、癫痫、帕金森病和多发性硬化的比值比(OR)。

主要发现

  • 痴呆见于622例天疱疮患者(31.3%)vs 1856名对照(18.8%),OR 1.97(95%CI 1.77-2.20)。
  • 癫痫见于74例天疱疮患者(3.7%)vs 210名对照(2.1%),OR 1.78(95%CI 1.36-2.33)。
  • 帕金森病见于175例天疱疮患者(8.8%)vs 437名对照(4.4%),OR 2.09(95%CI 1.74-2.51)。
  • 多发性硬化见于2例天疱疮患者(0.1%)vs 6名对照(0.01%),OR 1.65(95%CI 0.34-8.22)。
  • 敏感性分析仅纳入接受长期天疱疮特异性药物(糖皮质激素、免疫抑制剂或利妥昔单抗)治疗的患者,结果稳健;控制合并症和医疗过度使用后估计值无显著改变。

临床怎么用

  • 医生治疗天疱疮患者时应意识到与痴呆、帕金森病和癫痫可能的关联。
  • 天疱疮患者应仔细评估是否合并神经系统疾病并接受适当治疗。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

IMPORTANCE: The association between pemphigus and neurologic diseases was not evaluated systematically in the past. In a recent uncontrolled cross-sectional study, Parkinson disease was found to be significantly associated with pemphigus; in the same study, epilepsy had a nonsignificant association with pemphigus. Several case reports have suggested that pemphigus coexists with multiple sclerosis and dementia. OBJECTIVE: To estimate the association between pemphigus and 4 neurologic conditions (dementia, epilepsy, Parkinson disease, and multiple sclerosis), using one of the largest cohorts of patients with pemphigus. DESIGN, SETTING, AND PARTICIPANTS: A retrospective population-based cross-sectional study was performed between January 1, 2004, and December 31, 2014, using the database of Clalit Health Services, the largest public health care organization in Israel, in the setting of general community clinics, primary care and referral centers, and ambulatory and hospitalized care. A total of 1985 patients with a new diagnosis of pemphigus and 9874 controls were included in the study. MAIN OUTCOMES AND MEASURES: The proportion of dementia, epilepsy, Parkinson disease, and multiple sclerosis was compared between patients diagnosed with pemphigus and age-, sex-, and ethnicity-matched control participants. Logistic regression was used to calculate odds ratios (ORs) for dementia, epilepsy, Parkinson disease, and multiple sclerosis. The association was examined after a sensitivity analysis that included only patients treated with long-term, pemphigus-specific medications (corticosteroids, immunosuppressants, or rituximab) and after adjustment for several confounding factors. RESULTS: When comparing the 1985 cases (1188 women and 797 men; mean [SD] age, 72.1 [18.5] years) with the 9874 controls (5912 women and 3962 men; mean [SD] age, 72.1 [18.5] years), dementia was seen in 622 cases (31.3%) vs 1856 controls (18.8%), with an OR of 1.97 (95% CI, 1.77-2.20). Epilepsy was present in 74 cases (3.7%) vs 210 controls (2.1%), with an OR of 1.78 (95% CI, 1.36-2.33). Parkinson disease was seen in 175 cases (8.8%) vs 437 controls (4.4%), with an OR of 2.09 (95% CI, 1.74-2.51). Multiple sclerosis was present in 2 cases (0.1%) vs 6 controls (0.01%), with an OR of 1.65 (95% CI, 0.34-8.22). Study findings were robust to sensitivity analysis that included patients receiving pemphigus-specific treatments. Estimates were not altered significantly after controlling for comorbidities and overuse of health care. CONCLUSIONS AND RELEVANCE: An association was observed between pemphigus and specific neurologic diseases, including dementia, Parkinson disease, and epilepsy. Physicians treating patients with pemphigus should be aware of this possible association. Patients with pemphigus should be carefully assessed for comorbid neurologic disorders and receive appropriate treatment.

来源:JAMA Dermatol,查看原文。版权归原作者所有。

引用

  1. Kridin K, Zelber-Sagi S, Comaneshter D, et al. Association Between Pemphigus and Neurologic Diseases. JAMA Dermatol. 2018. PMID: 29453873. doi:10.1001/jamadermatol.2017.5799

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。